3D BIOPRINTING MARKET ANALYSIS

3D Bioprinting Market, By Technology (Syringe/extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, and Others), By Component (3D Bioprinters, Biomaterials, and Scaffolds), By Application (Drug Testing and Development, Regenerative Medicine, Food Testing, Research, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

In August 2023, Cellink (Sweden) which is a is a bioconvergence startup, revealed the Bio X3 bioprinter, a versatile device capable of printing various materials such as cells, hydrogels, and biomolecules. Cellink’s Bio X is a standalone 3D bioprinter with three interchangeable printheads suitable for a variety of bioinks and biomaterials.
In September 2022, the Indian Institute of Science (IISc) collaborated with CELLINK which is a is a bioconvergence startup, to establish a Center of Excellence (CoE) for 3D bioprinting. IISc plans to set up the CoE at its Centre for Biosystems Science and Engineering (BSSE) and provide two to three bioprinters, each utilizing different printing technologies.
In June 2022, REGEMAT 3D which develops Customized Bioprinting systems, partnered with Humabiologics is a regenerative medicine startup, to address the growing demand in the European bioprinting and drug testing market. This collaboration aims to serve a broader life sciences customer base, combining REGEMAT 3D's personalized biofabrication solutions with Humabiologics' human-derived biomaterials for regenerative medicine.